CARDIO-NOTES
📈 Analytical overview of Telegram channel CARDIO-NOTES
Channel CARDIO-NOTES (@cardionotesposts) in the Arabic language segment is an active participant. Currently, the community unites 13 985 subscribers, ranking 1 898 in the Medicine category and 1 859 in the Egypt region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 13 985 subscribers.
According to the latest data from 27 October, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 107 over the last 30 days and by 0 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 33.41%. Within the first 24 hours after publication, content typically collects N/A% reactions from the total number of subscribers.
- Post reach: On average, each post receives 0 views. Within the first day, a publication typically gains 0 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 0.
- Thematic interests: Content is focused on key topics such as مَرِيض, ضَغط, عِلَاج, حَالَة, جُرعَة.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“قناة خاصة بمنشورات طوارئ وعيادة القلب”
Thanks to the high frequency of updates (latest data received on 28 October, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Loading data
| Date | Subscriber Growth | Mentions | Channels | |
| 28 October | 0 | |||
| 27 October | 0 | |||
| 26 October | +2 | |||
| 25 October | +4 | |||
| 24 October | 0 | |||
| 23 October | +5 | |||
| 22 October | +5 | |||
| 21 October | 0 | |||
| 20 October | 0 | |||
| 19 October | 0 | |||
| 18 October | +3 | |||
| 17 October | 0 | |||
| 16 October | +1 | |||
| 15 October | +3 | |||
| 14 October | +1 | |||
| 13 October | +4 | |||
| 12 October | 0 | |||
| 11 October | +1 | |||
| 10 October | +4 | |||
| 09 October | +2 | |||
| 08 October | +13 | |||
| 07 October | +4 | |||
| 06 October | +23 | |||
| 05 October | +37 | |||
| 04 October | +1 | |||
| 03 October | +4 | |||
| 02 October | +3 | |||
| 01 October | 0 |
| 2 | معدل نجاح المذيب في حالات ال STEMI في فتح الشريان واعادة سريان الدم متفاوت حسب الدواء المستخدم
90-minute Patency Rate (TIMI 2–3 flow):
🔹 Streptokinase: 60–68%
🔹 Alteplase (tPA): 73–84%
🔹 Reteplase (rPA): 84%
🔹 Tenecteplase (TNK-tPA): 85%
الأدوية الحديثة (Fibrin-specific agents) تحقق معدلات أعلى لفتح الشريان مقارنة بالـ Streptokinase
النسب دي كمان لل TIMI2 or 3 مش بالضرورة سريان الدم يكون رجع طبيعي (اللي هيكون محتاج قسطرة في كل الاحوال)
#cardionotes | 243 |
| 3 | حسب الارشادات الامريكية ٢٠٢٥ لعلاج الضغط
تقدر توصل بجرعة ال
Labetalol
لغاية ٢٤٠٠ مج في اليوم
وجرعة ال
Nifedipine
لغاية ١٢٠ مج يوميا
وجرعة ال
Methyldopa
لغاية ٣٠٠٠ مج يوميا
لعلاج الضغط أثناء الحمل
#cardionotes | 224 |
| 4 | According to ESC 2024, which patient is the most appropriate candidate for initial monotherapy rather than dual therapy?
A. A 55-year-old with uncomplicated HTN, BP 160/100 mmHg.
B. A 60-year-old with HTN, BP 152/96 mmHg.
C. A 58-year-old with established CVD, BP 134/84 mmHg despite 3 months of lifestyle modification.
D. A 48-year-old with uncomplicated HTN, BP 154/94 mmHg.
#cardionotes | 207 |
| 5 | امتصاص ال
Rivaroxaban
جزء كبير منه بيتم في المعدة
علشان كدا في حالات تحويل المسار او عمليات المعدة اللي بتآثر على مساحة الامتصاص لا يفضل خوفا من تاثر امتصاصه
ال
Apixaban
الجزء الاكبر منه يمتص في الامعاء وربما يكون اختيار افضل نسبيا في هذه الحالات من الاخر
#cardionotes | 159 |
| 6 | عملت عملية تحويل مسار من ٧ سنوات
ثم عانت ذبذبة اذينية من ٥ سنوات تستدعي دواء سيولة
تم وصف
Rivaroxaban
✅✅✅✅
ال rivaroxaban لا يفضل في هذه الحالة (حالات تحويل المسار او تكميم المعدة)
هناك توصية في الارشادات الامريكية تفضل الماريفان
Warfarin
على ال DOAC
اما لو هتستخدم DOAC فلافضل هو ال
Apixaban.
#cardionotes | 151 |
| 7 | In patients with DHF, fluid intake should be less than urine output and fluid restriction may be appropriate in patients with hyponatraemia, based on individual assessment.
#cardionotes | 121 |
| 8 | في حالات ال
Decompensated heart failure
حاليا بتبدا بال
IV diuretic
(٤٠ مج لازكس لمريض مكنش بياخد ادوية مدرة للبول م قبل او ضعف الجرعة المستخدمة يوميا لمريض كان بيستخدم مدر للبول)
بعد كدا امامك خيارين لو الاستجابة غير كافية
اما ترفع جرعة ال loop diuretic اللي استخدمته للضعف
او تضيف واحد من الاتي
Acetazolamide
Or hydrochlorothiazide
ESC 2026
#cardionotes | 145 |
| 9 | Heart failure and AF frequently coexist, with AF occurring in more than half of patients with HF, and HF occurring in more than one-third of patients with AF.
#cardionotes | 139 |
| 10 | Criteria for Endotracheal Intubation in DHF
Cardiac or respiratory arrest.
Progressive worsening of altered mental status.
Progressive worsening of respiratory failure with hypoxaemia (PaO₂ <60 mmHg, PaCO₂ >50 mmHg, pH <7.35) despite NIV or intolerance to NIV.
Persistent haemodynamic instability.
Need for airway protection.
ESC 2026
#cardionotes | 139 |
| 11 | No ARB has reduced all-cause mortality in any trial in HFrEF patients, and combination with an ACE-I increases adverse effects.
ESC 2026 HF
#cardionotes | 133 |
| 12 | CRT vs. RV Pacing in HFrEF
In patients with HFrEF who require ventricular pacing due to high-degree AV block, CRT should be considered instead of conventional RV pacing to reduce HF hospitalizations and mortality.
This applies regardless of NYHA class or QRS duration.
Class IIa
ESC 2026
#cardionotes | 147 |
| 13 | قبل خروج مريض الـ Decompensated HF من المستشفى، لازم نكون:
بدأنا الـ Foundational Medical Therapy (الأدوية الأربعة الأساسية لعلاج هبوط عضلة القلب، ما لم يكن هناك مانع).
اتأكدنا من عدم وجود Residual Congestion.
#cardionotes | 168 |
| 14 | Treatment with ACE-Is or ARNIs is indicated, but should be given with caution, to patients with low blood pressures (systolic blood pressure <100 mmHg), kidney insufficiency (eGFR <30 mL/min/ 1.73 m 2 ), or elevated serum potassium (>5.2 mEq/L).
#cardionotes | 181 |
| 15 | In patients admitted with DHF, beta-blockers should be cautiously initiated in hospital, once the patient is haemodynamically stabilized
#cardionotes | 181 |
| 16 | أغلب أمراض القلب لا تمنع من الحمل
Heart disease does not preclude successful pregnancy, but it does increase the risk of complications for both mother and fetus and therefore requires special management.
#cardionotes | 182 |
| 17 | With BB therapy in HFrEF
Even if symptoms do not improve, long-term treatment should be maintained to reduce the risk of major CV events.
#cardionotes | 412 |
| 18 | Angiotensin II receptor blockers are recommended for HFrEF patients who cannot tolerate ACE-Is or ARNIs
ESC 2026
#cardionotes | 405 |
| 19 | بشكل عام بلاش الحديد يتاخذ مع ال
Methyldopa
في نفس الوقت
الحديد بيقلل امتصاصه
الاتنين بيستخدموا اثناء الحمل بكثرة
افصل بين الاتنين بساعتين او اكتر
والاهم تابع مفعول ال methyldopa مع معظم تركيبات الحديد
#cardionotes | 394 |
| 20 | Iron deficiency is slightly more prevalent in patients with HFpEF than in patients with HFrEF.
#cardionotes | 370 |
